Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, phase IV clinical trial in Brazil

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health
  • Foundation for the National Institutes of Health (UL1 TR001085)
  • National Center for Research Resources
  • National Center for Advancing Translational Sciences (UL1 TR001085)
  • Coalition for Epidemic Preparedness Innovations

This publication has 20 references indexed in Scilit: